Philipp Probst

553 total citations
26 papers, 400 citations indexed

About

Philipp Probst is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Philipp Probst has authored 26 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in Philipp Probst's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Philipp Probst is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Philipp Probst collaborates with scholars based in Switzerland, United States and Germany. Philipp Probst's co-authors include Dario Neri, Teresa Hemmerle, Tim Fugmann, Leonardo Giovannoni, Danilo Ritz, T Meyer, H Bürgi, Andreas Barth, L D Olson and Michael F. Barile and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Philipp Probst

24 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Probst Switzerland 11 183 179 118 91 41 26 400
Jaswinder Kaur India 10 79 0.4× 184 1.0× 20 0.2× 81 0.9× 11 0.3× 29 427
Sarah Roord Netherlands 12 57 0.3× 363 2.0× 62 0.5× 194 2.1× 12 0.3× 16 607
Noriyuki Otsuka Japan 11 82 0.4× 193 1.1× 23 0.2× 158 1.7× 8 0.2× 35 504
Keith K. Colburn United States 11 36 0.2× 122 0.7× 56 0.5× 83 0.9× 9 0.2× 28 338
Anja Williams United Kingdom 7 91 0.5× 292 1.6× 80 0.7× 85 0.9× 3 0.1× 13 454
Toshiyuki Ikemoto Japan 10 64 0.3× 136 0.8× 18 0.2× 77 0.8× 5 0.1× 35 355
R R Skelly United States 8 139 0.8× 248 1.4× 68 0.6× 172 1.9× 11 0.3× 16 473
Mickie Cheng United States 12 60 0.3× 284 1.6× 83 0.7× 137 1.5× 4 0.1× 20 618
Lydia Haile United States 12 230 1.3× 625 3.5× 56 0.5× 183 2.0× 12 0.3× 13 769
Natalija Gerasimčik Sweden 11 75 0.4× 154 0.9× 23 0.2× 107 1.2× 10 0.2× 15 372

Countries citing papers authored by Philipp Probst

Since Specialization
Citations

This map shows the geographic impact of Philipp Probst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Probst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Probst more than expected).

Fields of papers citing papers by Philipp Probst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Probst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Probst. The network helps show where Philipp Probst may publish in the future.

Co-authorship network of co-authors of Philipp Probst

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Probst. A scholar is included among the top collaborators of Philipp Probst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Probst. Philipp Probst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Probst, Philipp, et al.. (2025). Broadening the Therapeutic Window of ADCs Using Site-Specific Bioconjugation Showcased by an MMAE-Containing Peptide Linker in a CD79b-Targeting ADC. Molecular Cancer Therapeutics. 24(6). 803–815. 1 indexed citations
2.
Probst, Philipp, Romain Bertrand, Roger Santimaria, et al.. (2024). Abstract LB124: Targeting NaPi2b with a novel dual TOP1i ADC that shows excellent biophysical properties and high efficacy in vivo. Cancer Research. 84(7_Supplement). LB124–LB124. 1 indexed citations
3.
Stallhofer, Johannes, Julia Diegelmann, Philipp Probst, et al.. (2022). Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clinical and Translational Gastroenterology. 13(1). e00450–e00450. 10 indexed citations
4.
Schlereth, Bernd, Philipp Probst, Romain Bertrand, et al.. (2022). A CD79b Targeting ADC with Superior Anti-Tumor Activity and Safety Resulting in Significantly Improved Therapeutic Index (TI): Safe and Efficacious CD79b ADC. Blood. 140(Supplement 1). 11568–11569. 1 indexed citations
5.
Catalano, Marco, et al.. (2021). Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen. Cancer Immunology Immunotherapy. 70(11). 3183–3197. 10 indexed citations
6.
Spycher, Philipp René, et al.. (2021). Abstract 1842: CD79b targeting ADC with superior pharmacokinetic profile and anti-tumor activity. Cancer Research. 81(13_Supplement). 1842–1842. 2 indexed citations
7.
Rauen, Katrin, Claudia Späni, Maria Carmela Tartaglia, et al.. (2020). Quality of life after traumatic brain injury: a cross-sectional analysis uncovers age- and sex-related differences over the adult life span. GeroScience. 43(1). 263–278. 25 indexed citations
8.
9.
Probst, Philipp, et al.. (2020). Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response of tissue‐resident memory T cells against the AH1 rejection antigen. European Journal of Immunology. 50(10). 1591–1597. 14 indexed citations
10.
Rémi, Jan, Moritz Tacke, Philipp Probst, et al.. (2020). Congruence and Discrepancy of Interictal and Ictal EEG With MRI Lesions in Pediatric Epilepsies. Clinical EEG and Neuroscience. 51(6). 412–419. 10 indexed citations
11.
Probst, Philipp, et al.. (2019). Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice. Molecular Cancer Therapeutics. 18(9). 1544–1554. 13 indexed citations
12.
Puca, Emanuele, Philipp Probst, Patrizia Murer, et al.. (2019). The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8 + T cell activity and synergizes with immune checkpoint inhibitors. International Journal of Cancer. 146(9). 2518–2530. 40 indexed citations
13.
Probst, Philipp, et al.. (2018). Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine. Clinical Cancer Research. 25(2). 698–709. 26 indexed citations
14.
Probst, Philipp, Annette Oxenius, Mario P. Colombo, et al.. (2017). Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen. Cancer Research. 77(13). 3644–3654. 49 indexed citations
15.
Probst, Philipp & Dario Neri. (2014). Immunocytokines for Cancer Therapy. 5(1-2). 83–99. 2 indexed citations
16.
Hemmerle, Teresa, et al.. (2013). The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. British Journal of Cancer. 109(5). 1206–1213. 74 indexed citations
17.
Michahelles, Florian & Philipp Probst. (2012). Object circles. 1–4.
18.
Barth, Andreas, Philipp Probst, & H Bürgi. (1991). Identification of a subgroup of Graves’ disease patients at higher risk for severe ophthalmopathy after radioiodine. Journal of Endocrinological Investigation. 14(3). 209–212. 26 indexed citations
19.
Olson, L D, et al.. (1991). Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain. Infection and Immunity. 59(5). 1683–1689. 42 indexed citations
20.
Bürgi, H, et al.. (1986). [Radioiodine therapy in hyperthyroidism: reliability of a long-term follow-up scheme for the diagnosis and treatment of hyperthyroidism based on the family physician and on a central registry].. PubMed. 116(36). 1198–204. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaswinder Kaur Breakdown of academic impact, for papers by Sarah Roord Breakdown of academic impact, for papers by Noriyuki Otsuka Breakdown of academic impact, for papers by Keith K. Colburn Breakdown of academic impact, for papers by Anja Williams Breakdown of academic impact, for papers by Toshiyuki Ikemoto Breakdown of academic impact, for papers by R R Skelly Breakdown of academic impact, for papers by Mickie Cheng Breakdown of academic impact, for papers by Lydia Haile Breakdown of academic impact, for papers by Natalija Gerasimčik
Rankless by CCL
2026